semaglutide tablets reviews Rybelsus Tablet Wegovy weight-loss pill now available
Description
The Department of Health and Social Care (DHSC) has warned that the shortage of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) will continue, with supply not expected to return to normal until at least the end of 2024
Even if GLP-1 and GIP secretion are present in these scenarios, both hormones usually have decreased effectiveness
Variations in dosage and formulation may occur, and side effects like nausea or gastrointestinal discomfort are possible
He noted that the company has shown that patients can maintain weight loss of about 15% over two years while staying on Wegovy but that those who stop the drug regain weight
In: Dagogo-Jack S, ed
